DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $200,321,225 | +59.0% | 801,766 | +58.9% | 0.30% | +70.1% |
Q1 2024 | $126,008,460 | +6.8% | 504,599 | -1.8% | 0.18% | -0.6% |
Q4 2023 | $117,939,910 | -23.8% | 513,922 | -17.7% | 0.18% | -26.7% |
Q3 2023 | $154,838,264 | -1.6% | 624,098 | -4.8% | 0.24% | +6.1% |
Q2 2023 | $157,291,706 | -9.0% | 655,382 | -2.9% | 0.23% | -15.2% |
Q1 2023 | $172,768,971 | -21.1% | 674,948 | -18.2% | 0.27% | -26.8% |
Q4 2022 | $218,869,232 | -2.7% | 824,619 | -5.3% | 0.37% | -3.1% |
Q3 2022 | $225,019,000 | -20.1% | 871,055 | -21.6% | 0.38% | -14.8% |
Q2 2022 | $281,750,000 | -12.5% | 1,111,369 | +1.2% | 0.45% | +4.4% |
Q1 2022 | $322,154,000 | -5.8% | 1,098,269 | +5.4% | 0.43% | +0.7% |
Q4 2021 | $342,134,000 | -16.7% | 1,041,903 | -22.7% | 0.42% | -25.7% |
Q3 2021 | $410,641,000 | +8.1% | 1,348,408 | -4.7% | 0.57% | +9.6% |
Q2 2021 | $379,730,000 | +37.4% | 1,414,998 | +15.2% | 0.52% | +26.1% |
Q1 2021 | $276,399,000 | -11.9% | 1,228,003 | -13.1% | 0.41% | -21.4% |
Q4 2020 | $313,738,000 | +65.6% | 1,412,350 | +60.5% | 0.53% | +49.7% |
Q3 2020 | $189,453,000 | +82.8% | 879,827 | +50.1% | 0.35% | +78.7% |
Q2 2020 | $103,634,000 | +8.2% | 586,065 | -15.3% | 0.20% | -6.2% |
Q1 2020 | $95,810,000 | -6.1% | 692,212 | +4.1% | 0.21% | +40.0% |
Q4 2019 | $102,052,000 | -35.1% | 664,916 | -38.9% | 0.15% | -39.5% |
Q3 2019 | $157,218,000 | +32.2% | 1,088,534 | +30.9% | 0.25% | +34.8% |
Q2 2019 | $118,890,000 | -31.4% | 831,863 | -36.6% | 0.18% | -35.9% |
Q1 2019 | $173,336,000 | -21.9% | 1,312,953 | -39.0% | 0.29% | -26.2% |
Q4 2018 | $221,959,000 | -11.4% | 2,152,440 | -6.6% | 0.39% | +5.4% |
Q3 2018 | $250,445,000 | +4.7% | 2,304,848 | -4.9% | 0.37% | +3.4% |
Q2 2018 | $239,262,000 | +0.3% | 2,424,625 | -0.5% | 0.36% | -1.7% |
Q1 2018 | $238,590,000 | -3.8% | 2,436,831 | -8.8% | 0.36% | +7.4% |
Q4 2017 | $248,035,000 | +10.0% | 2,672,214 | +1.7% | 0.34% | +4.3% |
Q3 2017 | $225,480,000 | +7.0% | 2,628,584 | +5.2% | 0.32% | +3.2% |
Q2 2017 | $210,803,000 | +6.3% | 2,497,963 | +7.7% | 0.31% | +1.6% |
Q1 2017 | $198,321,000 | +26.7% | 2,318,733 | +15.3% | 0.31% | +22.6% |
Q4 2016 | $156,586,000 | +134.0% | 2,011,643 | +135.6% | 0.25% | +127.0% |
Q3 2016 | $66,928,000 | -26.7% | 853,788 | -5.6% | 0.11% | -27.9% |
Q2 2016 | $91,323,000 | -9.7% | 904,191 | -15.2% | 0.15% | -14.9% |
Q1 2016 | $101,127,000 | +35.4% | 1,066,056 | +32.5% | 0.18% | +34.1% |
Q4 2015 | $74,709,000 | -9.7% | 804,366 | -17.1% | 0.14% | -17.2% |
Q3 2015 | $82,709,000 | +20.1% | 970,646 | +20.6% | 0.16% | +33.6% |
Q2 2015 | $68,864,000 | -7.8% | 804,576 | -8.5% | 0.12% | -5.4% |
Q1 2015 | $74,664,000 | +9.0% | 879,436 | +10.0% | 0.13% | +4.0% |
Q4 2014 | $68,526,000 | +9.0% | 799,506 | -3.4% | 0.12% | +5.1% |
Q3 2014 | $62,877,000 | -10.7% | 827,546 | -7.5% | 0.12% | -4.8% |
Q2 2014 | $70,401,000 | +10.1% | 894,208 | +4.9% | 0.12% | +4.2% |
Q1 2014 | $63,961,000 | +9.8% | 852,806 | +13.0% | 0.12% | +2.6% |
Q4 2013 | $58,242,000 | +7.9% | 754,436 | -3.2% | 0.12% | +0.9% |
Q3 2013 | $54,002,000 | +10.5% | 779,026 | +0.9% | 0.12% | +6.5% |
Q2 2013 | $48,864,000 | – | 771,946 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |